State of the Art Symposium
SA 15 - Immunotherapy for cancer: do patients need targeted imaging?
Lectures
1
Chairperson's introduction
05:00Clarisse Dromain, Lausanne / CH
2
Immunotherapy: an oncologist's view
18:00Dirk De Ruysscher, Maastricht / NL
3
Standard imaging: limitations in assessing immunotherapy?
18:00Clarisse Dromain, Lausanne / CH
4
Molecular and hybrid imaging: what should we target?
18:00Egesta Lopci, Rozzano / IT
5
Predicting response to cancer immunotherapy using radiomics and artificial intelligence
18:00Stefano Trebeschi, Amsterdam / NL
